MAPPING THE HOST
RESPONSE IN BLOOD
Generating insights from tumor-host interaction in order to detect cancer as early as possible and tailor the right treatment for the right patient. We are pioneering the field of immuno-transcriptomics with passion for improving health outcomes.
MAPPING THE HOST
RESPONSE IN BLOOD
Generating insights from tumor-host interaction in order to detect cancer as early as possible and tailor the right treatment for the right patient. We are pioneering the field of immuno-transcriptomics with passion for improving health outcomes.
THE POWER OF PROFILING
IMMUNE CELLS IN BLOOD
The immuno-transcriptomic profiling of circulating immune cells holds promises for application in early cancer detection and immune monitoring. We strive to generate new biological insights from a simple blood draw by measuring gene expression changes in cells that play a critical role in recognizing and fighting tumors.
HOW WE DO IT
Our immuno-transcriptomics approach is a powerful diagnostic and mechanistic tool to map the response of the immune system to cancer’s onset, progression, and treatment. It consists of:
1. Isolate white blood cells from a patient’s blood sample and extracted its mRNA content.
2. Perform RNA-sequencing to search for specific transcriptional changes induced by the disease.
3. Apply our data analysis pipeline to interpret the transcriptional changes and provide actionable information.
